These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Differential in vitro activity of the DNA topoisomerase inhibitor idarubicin against Trypanosoma rangeli and Trypanosoma cruzi. Jobe M, Anwuzia-Iwegbu C, Banful A, Bosier E, Iqbal M, Jones K, Lecutier SJ, Lepper K, Redmond M, Ross-Parker A, Ward E, Wernham P, Whidden EM, Tyler KM, Steverding D. Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):946-50. PubMed ID: 23147154 [Abstract] [Full Text] [Related]
26. Quinoxaline N,N'-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure-activity relationships. Aguirre G, Cerecetto H, Di Maio R, González M, Alfaro ME, Jaso A, Zarranz B, Ortega MA, Aldana I, Monge-Vega A. Bioorg Med Chem Lett; 2004 Jul 16; 14(14):3835-9. PubMed ID: 15203172 [Abstract] [Full Text] [Related]
37. Leishmanicidal and trypanocidal activities of 2-aminocyclohexanol and 1,2-cyclohexanediamine derivatives. Rebollo O, del Olmo E, Ruiz G, López-Pérez JL, Giménez A, San Feliciano A. Bioorg Med Chem Lett; 2008 Jan 01; 18(1):184-7. PubMed ID: 18024033 [Abstract] [Full Text] [Related]
39. Synthesis of novel quinine analogs and evaluation of their effects on Trypanosoma cruzi. Ceole LF, Gandhi H, Villamizar LH, Soares MJ, O'Sullivan TP. Future Med Chem; 2018 Feb 01; 10(4):391-408. PubMed ID: 29380636 [Abstract] [Full Text] [Related]
40. Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity. Hartmann AP, de Carvalho MR, Bernardes LSC, Moraes MH, de Melo EB, Lopes CD, Steindel M, da Silva JS, Carvalho I. Eur J Med Chem; 2017 Nov 10; 140():187-199. PubMed ID: 28926763 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]